NCT03528577View on ClinicalTrials.gov

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

September 22, 2018

Primary Completion Date

March 11, 2019

Study Completion Date

August 3, 2019

Conditions
Asthma
Interventions
DRUG

Zero-dose

Treatment A

DRUG

90 mcg of PROAIR® HFA

Treatment B

DRUG

180 mcg of 90 mcg of PROAIR® HFA

Treatment C

DRUG

90 mcg of albuterol sulfate inhalation aerosol

Treatment D

Trial Locations (8)

20814

SPARC site 01, Bethesda

28054

SPARC Site 06, Gastonia

33014

SPARC Site 02, Miami Lakes

63141

SPARC Site 04, St Louis

73034

SPARC Site 05, Edmond

76712

SPARC Site 03, Waco

78006

SPARC Site 08, Boerne

02886

SPARC Site 07, Warwick

All Listed Sponsors
lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT03528577 - A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) | Biotech Hunter | Biotech Hunter